Serum Resistin Concentrations and Risk of New Onset Heart Failure in Older Persons
Author(s) -
Javed Butler,
Andreas P. Kalogeropoulos,
Vasiliki V. Georgiopoulou,
Nathalie de Rekeneire,
Nicolas Rodondi,
Andrew L. Smith,
Udo Hoffmann,
Alka M. Kanaya,
Anne B. Newman,
Stephen B. Kritchevsky,
Ramachandran S. Vasan,
Peter W.F. Wilson,
Tamara B. Harris
Publication year - 2009
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.109.186783
Subject(s) - resistin , medicine , adipokine , ejection fraction , insulin resistance , heart failure , diabetes mellitus , proportional hazards model , endocrinology , cardiology
Resistin is associated with inflammation and insulin resistance and exerts direct effects on myocardial cells including hypertrophy and altered contraction. We investigated the association of serum resistin concentrations with risk for incident heart failure (HF) in humans.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom